641 related articles for article (PubMed ID: 23396314)
21. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
22. A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
Morfa CJ; Bassoni D; Szabo A; McAnally D; Sharir H; Hood BL; Vasile S; Wehrman T; Lamerdin J; Smith LH
Assay Drug Dev Technol; 2018 Oct; 16(7):384-396. PubMed ID: 30251873
[TBL] [Abstract][Full Text] [Related]
23. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
24. β-arrestins and G protein-coupled receptor trafficking.
Tian X; Kang DS; Benovic JL
Handb Exp Pharmacol; 2014; 219():173-86. PubMed ID: 24292830
[TBL] [Abstract][Full Text] [Related]
25. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
[TBL] [Abstract][Full Text] [Related]
26. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
27. Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay.
Zeghal M; Laroche G; Giguère PM
J Vis Exp; 2020 Mar; (157):. PubMed ID: 32225148
[TBL] [Abstract][Full Text] [Related]
28. Arrestin recruitment and signaling by G protein-coupled receptor heteromers.
Mores KL; Cassell RJ; van Rijn RM
Neuropharmacology; 2019 Jul; 152():15-21. PubMed ID: 30419245
[TBL] [Abstract][Full Text] [Related]
29. In-Cell Arrestin-Receptor Interaction Assays.
Zheng C; Javitch JA; Lambert NA; Donthamsetti P; Gurevich VV
Curr Protoc; 2023 Oct; 3(10):e890. PubMed ID: 37787634
[TBL] [Abstract][Full Text] [Related]
30. Beta-arrestin-biased ligands at seven-transmembrane receptors.
Violin JD; Lefkowitz RJ
Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
[TBL] [Abstract][Full Text] [Related]
31. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
32. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2.
Stroth N; Niso M; Colabufo NA; Perrone R; Svenningsson P; Lacivita E; Leopoldo M
Bioorg Med Chem; 2015 Aug; 23(15):4824-4830. PubMed ID: 26081758
[TBL] [Abstract][Full Text] [Related]
33. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
Laroche G; Giguère PM
Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
[TBL] [Abstract][Full Text] [Related]
34. Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.
Park JY; Lee SY; Kim HR; Seo MD; Chung KY
Arch Pharm Res; 2016 Mar; 39(3):293-301. PubMed ID: 26825061
[TBL] [Abstract][Full Text] [Related]
35. Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling.
Barsi-Rhyne B; Manglik A; von Zastrow M
Elife; 2022 Oct; 11():. PubMed ID: 36250629
[TBL] [Abstract][Full Text] [Related]
36. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions.
Lee MH; Appleton KM; Strungs EG; Kwon JY; Morinelli TA; Peterson YK; Laporte SA; Luttrell LM
Nature; 2016 Mar; 531(7596):665-8. PubMed ID: 27007854
[TBL] [Abstract][Full Text] [Related]
37. Identification of Drosophila neuropeptide receptors by G protein-coupled receptors-beta-arrestin2 interactions.
Johnson EC; Bohn LM; Barak LS; Birse RT; Nässel DR; Caron MG; Taghert PH
J Biol Chem; 2003 Dec; 278(52):52172-8. PubMed ID: 14555656
[TBL] [Abstract][Full Text] [Related]
38. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
[TBL] [Abstract][Full Text] [Related]
39. Many faces of the GPCR-arrestin interaction.
Kim K; Chung KY
Arch Pharm Res; 2020 Sep; 43(9):890-899. PubMed ID: 32803684
[TBL] [Abstract][Full Text] [Related]
40. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
